Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Long-term cohort studies

Topic: Health services, long-term care and technology

Using two large-scale longitudinal datasets covering more than 75,000 patients or stays and 7.8 million clinical observations—spanning emergency vasopressor titration in sepsis (MIMIC- IV; 6,243 ICU admissions drawn from 73,141 encounters) and serial cognitive assessment in Alzheimer’s disease (ADNI; 2,262 longitudinal participants)—we train a 13-family computa- tional model zoo and perform a novel experiment: auditing whether clinician and AI treatment decisions jointly or individually match the subsequent patient trajectory, and testing whether cooperation between the two actors resolves their disagreements. The experiment reveals that in acute care, where clinician–patient contact is brief, both clinician and AI share the same blind spot—neither matched the subsequent trajectory in 53% of treatment events, with neg- ligible cooperation surplus (< 0.003). In longitudinal care, the blind spot shrank to 11%, and the clinician’s accumulated private knowledge added up to 25 percentage points of directional information, but the model did not improve—clinical interaction enriches the clinician, not the model. Serial norepinephrine adjustments drove branch balance from 0.816 to 0.994, confirming that repeated treatment progressively erases directional identifiability. Seven dose-recommender families over-dosed at MAP 65 relative to clinicians by 12.5–104.2%. Direct measurement of serial trajectory deformation—how far the patient’s physiologic profile has drifted from its own initial shape—recovered 10–19 percentage points of directional resolution where action exchange added nothing. These findings show that the obstacle to safe clinical AI is not that clinicians and models need to cooperate better with the information they have. It is that neither agent currently measures the right thing: how treatment has changed the patient’s trajectory relative to its own history.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 31 of the 62 points it could be judged on, which is 50 of 100. Raw total 50 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 50 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 50 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for randomised / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 31 of the 62 points we could judge it on, which is 50 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (Research Square)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 75,000 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 31 / 62 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 31 of the 62 points we could judge it on is 50 out of 100.
Total 50 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Ewing, M. A. (2026). Intelligence Breaks the System It Controls. Research Square. https://doi.org/10.21203/rs.3.rs-10283184/v2

Vancouver

Ewing MA. Intelligence Breaks the System It Controls. Research Square. 2026. doi:10.21203/rs.3.rs-10283184/v2.

BibTeX

@article{ewing2026-38225c61,
  author  = {Ewing, M. A.},
  title   = {{Intelligence Breaks the System It Controls}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10283184/v2},
  url     = {https://doi.org/10.21203/rs.3.rs-10283184/v2}
}

Related studies in Long-term cohort studies

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →